Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. Stock Info Message Board

Evoke Pharma Inc. (EVOK) News Nov 20, 2014, 4:00 p

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 250674
Posted On: 11/21/2014 12:04:13 AM
Posted By: Savant
Evoke Pharma Inc. (EVOK) News Nov 20, 2014, 4:00 p.m.
MarketWatch News on EVOK
No News currently available for EVOK

Other News on EVOK
Supernus Pharmaceuticals (SUPN) in Focus: Stock Up 9.8% - Tale of the Tape 9:32 a.m. Nov. 19, 2014 - Zacks.com
Evoke Pharma's (EVOK) CEO Dave Gonyer on Q3 2014 Results - Earnings Call Transcript 9:04 p.m. Nov. 13, 2014 - Seeking Alpha
3 Stocks Pushing The Drugs Industry Lower 3:32 p.m. Sept. 5, 2014 - TheStreet.com
3 Drugs Stocks Pushing The Industry Higher 3:32 p.m. Aug. 20, 2014 - TheStreet.com
Evoke Pharma's (EVOK) CEO Dave Gonyer on Q1 2014 Results - Earnings Call Transcript 8:13 p.m. May 13, 2014 - Seeking Alpha
10-Q: EVOKE PHARMA INC 3:14 p.m. May 13, 2014 - Edgar Online - (EDG = 10Q, 10K)
Evoke Pharma's CEO Discusses Q4 2013 Results - Earnings Call Transcript 9:16 p.m. March 25, 2014 - Seeking Alpha
10-K: EVOKE PHARMA INC 3:14 p.m. March 25, 2014 - Edgar Online - (EDG = 10Q, 10K)
Evoke Pharma Moves Full Speed Ahead 7:46 p.m. Jan. 26, 2014 - Seeking Alpha
SA PRO: Top Long And Short Ideas, Thursday January 23 7:30 a.m. Jan. 24, 2014 - Seeking Alpha
Evoke shares surge following positive trial results 9:34 a.m. Jan. 22, 2014 - Seeking Alpha
Evoke Pharma May Be One Of The Safest Biotech Bets Of 2014 11:00 a.m. Jan. 14, 2014 - Seeking Alpha
Aegis looks for Evoke Pharma to increase sevenfold 9:14 a.m. Nov. 19, 2013 - Seeking Alpha
10-Q: EVOKE PHARMA INC 4:44 p.m. Nov. 13, 2013 - Edgar Online - (EDG = 10Q, 10K)
Press Releases on EVOK
Dr. Kenneth J. Widder Joins Quidel's Board of Directors 4:40 p.m. Nov. 19, 2014 - Marketwired
Evoke Pharma Reports Third Quarter 2014 Results 4:06 p.m. Nov. 13, 2014 - GlobeNewswire
Evoke Pharma Schedules Webcast and Conference Call for Third Quarter 2014 Financial Results 8:31 a.m. Nov. 6, 2014 - GlobeNewswire
Evoke Pharma Announces the Completion of Enrollment in Its Thorough ECG Study for EVK-001 7:31 a.m. Sept. 9, 2014 - GlobeNewswire
Evoke Pharma to Present at the Aegis Capital Corp. 2014 Healthcare & Technology Conference 7:37 a.m. Sept. 4, 2014 - GlobeNewswire
Evoke Pharma Reports Second Quarter 2014 Results 3:02 p.m. Aug. 13, 2014 - GlobeNewswire
Evoke Pharma Announces Initiation of a Thorough ECG (QT) Study for EVK-001 3:33 p.m. Aug. 12, 2014 - GlobeNewswire
Evoke Pharma Schedules Webcast and Conference Call for Second Quarter 2014 Financial Results 7:31 a.m. July 30, 2014 - GlobeNewswire
Evoke Pharma Secures $4.5 Million Loan Facility With Square 1 Bank 3:06 p.m. May 28, 2014 - GlobeNewswire
Evoke Pharma Reports First Quarter 2014 Results 3:06 p.m. May 13, 2014 - GlobeNewswire
Evoke Pharma Schedules Webcast and Conference Call for First Quarter 2014 Financial Results 7:31 a.m. May 6, 2014 - GlobeNewswire
Evoke Pharma Announces That EVK-001 Phase 2b Results Will be Presented at Digestive Disease Week 2014 7:31 a.m. April 28, 2014 - GlobeNewswire
Evoke Pharma Initiates Phase 3 Clinical Trial of EVK-001 for Treatment of Gastroparesis 7:31 a.m. April 22, 2014 - GlobeNewswire
Evoke Pharma Reports Fourth Quarter and Year End 2013 Results 3:30 p.m. March 25, 2014 - GlobeNewswire
Evoke Pharma Schedules Webcast and Conference Call for Fourth Quarter 2013 Financial Results 9:03 a.m. March 10, 2014 - GlobeNewswire
Evoke Pharma to Present at 26th Annual ROTH Conference 8:30 a.m. March 4, 2014 - GlobeNewswire
Evoke Pharma Study Reports Positive Results of Metoclopramide Nasal Spray for Gastroparesis in Diabetics 8:30 a.m. Jan. 22, 2014 - GlobeNewswire
Evoke Pharma to Present at Biotech Showcase(TM) 2014 8:31 a.m. Jan. 7, 2014 - GlobeNewswire
Evoke Pharma Strengthens Executive Team With Appointments of Chief Medical Officer and Senior Director of Clinical Operations 8:30 a.m. Dec. 2, 2013 - GlobeNewswire
Evoke Pharma Selects SynteractHCR as Contract Research Organization for Phase 3 Trial of EVK-001 for Gastroparesis 8:30 a.m. Nov. 26, 2013 - GlobeNewswire



(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us